MCKESSON WKN: 893953 ISIN: US58155Q1031 Kürzel: MCK Forum: Aktien Thema: Hauptdiskussion

McKesson Corporation Reports Fiscal Fourth-Quarter and Full-year Results and Raises Long-Term Segment Growth Targets https://www.mckesson.com/About-McKesson/Newsroom/Press-Releases/2023/McKesson-Reports-Fiscal-2023-Fourth-Quarter-Full-Year-Results/

https://www.benzinga.com/pressreleases/23/07/b33342907/mckesson-raises-quarterly-dividend-by-15-to-0-62-per-share McKesson Raises Quarterly Dividend by 15% to $0.62 Per Share

- Adj EPS: $7.27 (est  $5.86) - Revenue: $74.5B (est  $70.12B)

https://www.businesswire.com/news/home/20230801510861/en/

https://www.businesswire.com/news/home/20231031995376/en/ McKesson Corporation Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance

McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M https://seekingalpha.com/news/3930812-mckesson-non-gaap-eps-of-6_90-beats-0_54-revenue-of-70_5b-misses-480m • McKesson press release (NYSE:MCK): Q3 Non-GAAP EPS of $6.90 beats by $0.54. • Revenue of $70.5B (+2.8% Y/Y) misses by $480M. • ... • Increased fiscal 2023 Adjusted Earnings per Diluted Share guidance range to $25.75 to $26.15, from the previous range of $24.45 to $24.95 vs. $24.80 consensus

https://www.businesswire.com/news/home/20230131006173/en/McKesson-Corporation-Reports-Fiscal-2023-Third-Quarter-Results

McKesson (NYSE:MCK) Price Target Increased to $420.00 by Analysts at Morgan Stanley https://www.marketbeat.com/instant-alerts/nyse-mck-a-buy-or-sell-right-now-2023-01/

Produzieren die auch Medikamente oder vertreiben sie sie nur?

https://seekingalpha.com/news/3899031-mckesson-non-gaap-eps-of-6_06-misses-0_03-revenue-of-70_2b-beats-120m McKesson Non-GAAP EPS of $6.06 misses by $0.03, revenue of $70.2B beats by $120M • McKesson press release (NYSE:MCK): Q2 Non-GAAP EPS of $6.06 misses by $0.03. • Revenue of $70.2B (+5.4% Y/Y) beats by $120M. • Fiscal 2023 Outlook: • Increased fiscal 2023 Adjusted Earnings per Diluted Share guidance range to $24.45 to $24.95, from the previous range of $23.95 to $24.65 from prior outlook of $23.95-$24.65 vs. $24.50 consensus

McKesson Corporation Reports Fiscal 2023 Second-Quarter Results and Raises Full-Year Guidance https://www.businesswire.com/news/home/20221101005938/en/McKesson-Corporation-Reports-Fiscal-2023-Second-Quarter-Results-and-Raises-Full-Year-Guidance

McKesson Signs Agreement to Acquire Rx Savings Solutions https://www.businesswire.com/news/home/20220918005071/en/McKesson-Signs-Agreement-to-Acquire-Rx-Savings-Solutions Acquisition aligns with McKesson’s strategic growth focus by connecting biopharma and payer services to patients ...

https://seekingalpha.com/news/3866363-mckesson-non-gaap-eps-of-5_83-beats-0_53-revenue-of-67_2b-beats-2_38b?utm_source=mystocksportfolio.app&utm_medium=referral

https://www.webullapp.com/news-detail/52219615?__app_cfg__=%7B%22supportTheme%22%3Atrue%2C%22sourcePage%22%3A%22StockNews%22%7D&tickerId=913323715&disSymbol=MCK&theme=1&color=2&hl=en&android_sdk_int=30&canary-version=&_v=1&sp=1&statusBarHeightV2=25

McKesson Raises Quarterly Dividend by 15% to $0.54 Per Share https://www.businesswire.com/news/home/20220723005007/en/McKesson-Raises-Quarterly-Dividend-by-15-to-0.54-Per-Share ...declared on July 22, 2022 a regular dividend of $0.54 per share of common stock, a 15% increase from $0.47 per share in the prior quarter. The dividend will be payable on October 3, 2022, to stockholders of record on September 1, 2022. ...